Pharmafile Logo
Pharmafocus logo
Advanced Search
EMA inside

Actelion’s Uptravi and rare bleeding disorder drug get positive EMA decisions

February 1, 2016
Sales and Marketing CHMP, EMA, Uptravi, pulmonary arterial hypertension, selexipag

The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the EMA, has issued positive opinions on …

News
Empliciti pack shot

EMA fast-tracks BMS multiple myeloma drug

February 1, 2016
Sales and Marketing AbbVie, BMS, Bristol-Myers Squibb, EMA, Empliciti, myeloma

The EMA has recommended granting a marketing authorisation for Bristol Myers-Squibb and AbbVie’s immunotherapy Empliciti for the treatment of multiple myeloma. The …

News
john_milligan_gilead_sciences

Gilead Sciences names John Milligan new CEO

January 29, 2016
Medical Communications, Sales and Marketing Gilead Sciences, John Martin, John Milligan

Gilead Sciences has announced that chairman and chief executive John Martin is to step down after 20 years at the …

Appointment
allergan

Allergan’s depression drug awarded FDA Breakthrough Therapy status

January 29, 2016
Research and Development, Sales and Marketing Allergan, depression, rapastinel

While still adjusting to life as part of Pfizer, Allergan has received some good news in the form of the …

News
business_generic

Pharma: How to make mergers work

January 29, 2016
Sales and Marketing mergers and acquisitions

Pharma is no stranger to bursts of M&A activity.

Feature
ABPI code

Regulation of drug promotion ‘should be toughened up’, study finds

January 29, 2016
Medical Communications ABPI Code, Department of Justice, PMCPA, Prescription Medicines Code of Practice Authority, Sunshine Act, marketing, off label, off-label, promotion

The voluntary code of conduct system that regulates the pharma industry’s promotion of off-label prescribing has a ‘limited capacity’ to …

News
Merck image

MSD gets FDA approval for hepatitis C drug Zepatier

January 29, 2016
Medical Communications, Sales and Marketing FDA, MSD, Zepatier, hepatitis C

The competitive hepatitis C market is to get another contender, with FDA approving MSD’s new combo treatment Zepatier (elbasvir and …

News
clinical trial patient

FDA plans greater diversity in clinical trials

January 29, 2016
Medical Communications, Research and Development FDA, Robert Califf, clinical trial, patient recruitment

The FDA is to focus on increasing patient diversity in clinical trials in 2016, to “ensure that research participants are …

News
Sanofi production

Sanofi expands Iranian presence with memorandum agreement

January 29, 2016
Manufacturing and Production, Medical Communications Iran, Sanofi, Serge Weinberg

Sanofi has become the latest pharmaceutical company to expand its presence in post-sanctions Iran, signing a memorandum of co-operation with …

News

Aslan Pharmaceuticals appoints eminent cancer researcher to chair scientific advisory board

January 28, 2016
Research and Development Aslan, Professor Sir David Lane

Aslan Pharmaceuticals has appointed four global cancer experts to its new scientific advisory board.The Board will be chaired by the …

Appointment
christina_a_wilbur

New HR head as Roche makes corporate executive committee changes

January 28, 2016
Medical Communications Roche

The Board of Directors has appointed Cristina Wilbur to succeed Silvia Ayyoubi as head of group human resources and member …

Appointment
opdivo

BMS says Phase III Opdivo head and neck cancer trial stopped early

January 28, 2016
Medical Communications, Research and Development

Bristol Myers Squibb has announced a Phase III study of Opdivo (nivolumab) in head and neck cancer patients was stopped early …

News
dr_reddys_building

Indian pharma market set to grow to $55 billion by 2020

January 28, 2016
Sales and Marketing GlobalData

The pharmaceuticals market in India, valued at $20 billion in 2015, is set to soar to $55 billion by 2020, …

News
roche_glass_building

Roche beats estimates with strong 2015 sales

January 28, 2016
Medical Communications, Sales and Marketing Esbriet, Herceptin, Roche, avastin

Roche reported full-year financial results today, beating analysts’ estimates, with the Swiss drugmaker announcing Group sales increases for 2015 in …

News
Lynparza

AZ’s Lynparza gets prostate cancer breakthrough status

January 28, 2016
Sales and Marketing AstraZeneca, Breakthrough Therapy Designation, FDA, lynparza, olaparib, prostate cancer

AstraZeneca’s Lynparza has been granted breakthrough therapy designation by the FDA as a monotherapy for the treatment of a specific …

News
Brain scan

Lilly and Roche team up on new Alzheimer’s diagnostic test

January 28, 2016
Research and Development Alzheimer's disease, Diagnostics, Roche, dementia, lilly

Eli Lilly has partnered with Roche Diagnostics to advance its development of a cerebrospinal fluid test for amyloid-beta 1-42, which …

News
Joseph Jimenez

Novartis braces for cuts after mixed 2015 performance

January 28, 2016
Sales and Marketing Novartis, financial results, revenue, sales

Net sales at Novartis fell by 5% in 2015 – prompting the company to make billion-dollar changes to its business …

News
Eric Low

Open access research partnership to ‘crowdsource’ new myeloma drugs

January 27, 2016
Research and Development Myeloma UK, Structural Genomics Consortium, collaboration, eric low, myeloma, partnership

Myeloma UK and the Structural Genomics Consortium (SGC) have entered into an open-access research partnership to find new drug targets …

News
alcon_ceo_mike_ball

Former Hospira boss joins Alcon as Novartis makes senior leadership changes

January 27, 2016
Novartis

Swiss firm Novartis has announced several leadership changes, effective February 1, 2016.In a briefing to present the company’s financial results, …

Appointment
merck_vib_m_org_1_rbvyvm_4c-01

New biopharma heads for Merck in North America and China

January 27, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Gary Zieziula, Mark Horn, Merck

Merck has made two appointments in its biopharma business: Gary Zieziula will lead Merck’s biopharma business in North America and …

Appointment
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026